The BioFabrication Cluster
Coalition Lead Applicant: City of Manchester
Region (applicant-defined): Southern New Hampshire
Phase 2 Federal Award: Approximately $44 million
The BioFabrication Cluster, led by the City of Manchester, will receive approximately $44 million to establish Southern New Hampshire as the global epicenter for the production and distribution of regenerative tissues and organs. Bringing engineered cells, tissues, and ultimately organs to patients will revolutionize healthcare, saving lives and reducing healthcare costs, while ensuring that the region realizes economic benefits. Having made significant progress in recent years, the cluster is at a tipping point where a series of targeted investments will complete the transition to market. EDA funding will be used to develop the BioFab Foundries for late-stage clinical and commercial manufacturing, a facility suitable for scaled production of cells, tissues, and organs as life-saving therapies. Currently, no U.S. facility has this outsourcing capacity. The coalition will implement five other projects, including the creation of a BioFabrication accelerator, a cluster work-and-learn program in partnership with community-based organizations, and pilot stations for an electric vertical take-off and landing logistics network to be used for future organ distribution. The BBBRC funding builds on upstream investments from the U.S. Department of Defense, complementing other federal resources by ensuring that benefits from cluster growth are directed to underserved communities in Southern New Hampshire.